Back

Editorial

India is now becoming a homoeopathy hub. It leads the world with highest number of homoeopaths around 200 homoeopathic colleges with university level education, streamlined quality control drugs, research, and clinical infrastructure in the field of homoeopathy. Homoeopathy visitors to India are increasing. Recently on the eve of World Homoeopathy Day, there were several international homoeopaths visiting India to participate various events. Being the Indian arm of internationally acclaimed Schwabe Group, Schwabe India attracted many. There were around 30 such international visitors to Schwabe India, who were astonished to see the World-Class GMP manufacturing facility with modern infrastructure in India as well.  Detailed information is given under Current news.

Young generation is the future of any society. It is true for homoeopathy. That is why Schwabe India has been encouraging the homoeopathic students across the country to visit and learn different aspects of manufacturing of good quality drugs from its state-of-the-art manufacturing facility. Over 800 students and faculty members have visited Schwabe India in a period of 3 months from April to June 2016. It is also given under Current news. Schwabe India has recently launched 5 new products and 4 product line extensions. They include Lilium tigr. Pentarkan, and 4 1x tablets viz. Baptisia tinctoria, Crataegus oxyacantha, Fucus vesiculosus and Sabal serrulata. Apart from these, four products of B&T Body Care range have been extended with new pack sizes, i.e. user-friendly pouches. Apart from this information, Schwabe India’s participation at the India International Yoga & Wellness Exhibition held at Pragati Maidan, New Delhi has also been covered under Current news.

Ficus religiosa, an Indian medicine with importance in Indian culture has been traditionally used for wide range of ailments of the central nervous system, endocrine system, gastrointestinal tract, reproductive system, respiratory system and infectious disorders. It was first introduced in homoeopathy in 1903 and first proved by Dr. S. C. Ghose. Recently Central Council for Research in Homoeopathy (CCRH) has published an elaborate proving. Curcuma longa is another Indian drug which has attracted the research interest globally. It was introduced in homoeopathy and published way back in 1977. CCRH had also proved this. We have come across another proving of Curcuma longa conducted at Durban University of Technology. Our “Provings and clinical verification” section covers both drugs with combined materia medica(s) of all reported provings.

This issue of Mother tincture info covers rare drugs Linum usitatissimum and Hepatica triloba. Their information with recent research reports are given.

Product watch covers 2 newly launched products, Lilium tigr. Pentarkan and Baptisia tinctoria 1x, and an existing product Kindival.

Research news reports two interesting studies. In the first study, individualised homoeopathic treatment (IHT), on clinical and quality of life (QoL) against placebo in patients suffering from advanced cancer and receiving conventional palliative care has shown statistically significant (compared to placebo) improvement. In the second study, Kindival has shown to be safe and effective in the treatment of sleep disorders in children. This was a prospective, multicenter, randomized, open-label, comparative, and controlled study.

Hope the issue will be informative.

Dr. R. Valavan, BHMS, MD (Hom), MBA

Editor